For practitioner dispensing and professionally guided use.
Always read the label and follow the directions for use.
Contraindicated in gastro-oesophageal reflux.
Peppermint may relax the lower oesophageal sphincter and worsen heartburn or acid reflux in susceptible people.
Use cautiously if you have gallstones, bile-duct obstruction or another biliary condition.
Seek prompt medical assessment for severe pain beneath the right ribs, fever, jaundice, persistent vomiting, dark urine or pale stools.
Use during pregnancy only under the supervision of a qualified healthcare practitioner.
Caution is required during breastfeeding because the current product information notes that Peppermint may reduce milk production.
Consult a qualified healthcare practitioner before use if you take prescription medicines or are receiving treatment for an existing digestive, gallbladder or liver condition.
No specific medicine interactions are identified in the European Peppermint Leaf monograph, but this does not guarantee suitability with every medication or medical condition.
Do not use Peppermint as a substitute for medical investigation of persistent nausea, abdominal pain, altered bowel habits or unexplained digestive symptoms.
Do not transfer claims involving enteric-coated peppermint oil capsules directly to this Peppermint Leaf liquid extract.
Research involving peppermint oil for irritable bowel syndrome does not establish that this 1:2 leaf extract treats IBS.
Do not use Peppermint as a substitute for medical treatment of influenza, COVID-19, pneumonia or another respiratory infection.
Persistent or worsening cough, high fever, shortness of breath, chest pain, confusion or marked weakness requires medical assessment.
Persistent or severe menstrual pain should be assessed, particularly when accompanied by very heavy bleeding, pain outside menstruation, faintness or sudden changes in the menstrual cycle.
The current product provides an adult dosage only.
Do not give this concentrated 45% ethanol practitioner preparation to a child or adolescent unless an age-appropriate amount has been individually prescribed.
European guidance for peppermint teas and 1:5 tinctures should not automatically be transferred to this Australian 1:2 liquid preparation.
Discontinue use seven days before general anaesthesia, surgery or an invasive procedure unless otherwise directed by your treating healthcare professional.
Contains ethanol.
Keep out of reach of children.